# Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial

> **NCT00520338** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 80 (estimated)

## Conditions studied

- Postoperative Pain
- Thyroidectomy
- Cyclooxygenase 2 Inhibitors

## Interventions

- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT00520338
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520338, "Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00520338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*